Portfolio Companies News
July 16, 2019Targovax announces start of the exp...
July 15, 2019 Press release - Non-regulatory Oslo, Norway, 15 July 2019: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces the start of the expansion part... read more
July 12, 2019GenSight Biologics completes enroll...
Paris, France, July 11, 2019, 5.45 pm CEST – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced... read more
July 11, 2019Nordic Nanovector completes patient...
11.07.2019 14:32 Oslo, Norway, 11 July 2019 Nordic Nanovector ASA (OSE: NANO) announces that the final patient has been enrolled in the LYMRIT 37-05 clinical trial of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) n... read more
July 11, 2019Orexo Interim Report Q2 2019
Improving all fundamentals Q2 2019 highlights Total net revenues of SEK 201.2 million (199.7), up 0.8 percent and 19.1 percent when excluding ex-US milestone payment of SEK 30.8 million in Q2 2018 Zubsolv® US net revenues of SEK 184.4 million (158.4), up 16.4 percent in SEK and 6.7 percent... read more
July 10, 2019Altimmune Signs Definitive Agreemen...
July 9, 2019 at 7:00 AM EDT PDF Version Company to receive rights to novel GLP-1/glucagon dual agonist that addresses obesity and metabolic dysfunction, primary causes of NASH Greater impact on liver fat, inflammation and fibrosis compared to leading NASH candidates in established... read more
May 10, 2019Q1 2019 General Market Overview
Since the start in 1996, HealthCap funds have invested in 114 portfolio companies.
42 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.